Qualigen Therapeutics (QLGN) announced that it will implement a 1-for-50 reverse stock split of the issued shares of its common stock, effective at 12:01 a.m. Eastern time on November 5, 2024. The Company’s common stock is expected to begin trading on a split-adjusted basis when the market opens on Tuesday, November 5, 2024, and will continue to trade on The Nasdaq Capital Market under the symbol “QLGN.”
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QLGN:
- Qualigen Therapeutics files to sell 14M shares of common stock
- Qualigen Therapeutics Board Experiences Key Changes
- Qualigen Therapeutics Announces Executive Shakeup and Board Revamp
- Qualigen Therapeutics appoints Kevin Richardson as Interim CEO and CFO
- Qualigen Therapeutics Granted Nasdaq Listing Extension